Featured in this edition of iSpeak Reading Roundup are the top blog posts from April 2019. See key industry topics, membership experiences, and more for what the pharmaceutical industry was reading last month.
ISPE has launched unlimited access for members to a brand-new webinar series including presentations from industry experts on crucial topics of interest in pharma manufacturing. Learn how to gain access to the upcoming series.
ICH Q12 is a quasi-management-based regulatory guideline that will impact facilities and product processing due to the addition of requirements for industry manufacturers. Find out how industry leaders can best prepare for the future of pharma regulation.
Global Day of the Engineer offers the opportunity for all types of engineers to be recognized for the innovative designs and equipment they create, especially for the pharma industry. Hear why engineers are proud to be leaders in the industry.
Explore the three-part series on new water distillation technology and how it will impact production and quality control. Cost control and end-product quality are key initiatives addressed in this technology overview.
See how young professionals can benefit from ISPE membership through networking, mentorship, and education events. ISPE focuses on encouraging career growth and individual skill development for future industry leaders.
In the pharmaceutical industry, which is highly regulated, aseptic processing is a critical component that ensures the sterility of products. Regulators have a set of comprehensive requirements that minimize the risk of contamination. Regulators set the requirements; however, the industry has an obligation to the patients who rely on and expect a drug that is safe and free of contamination....
Like any investment in digital manufacturing systems, demonstrating business payback before and after investment is critical to getting MES projects approved and verifying profitability after investment. Whether it is introducing MES, expanding it to additional sites, switching software, upgrading existing software, or developing electronic production records (EPR) for new drug products,...
Sustainability is emerging as a pivotal force influencing the pharmaceutical industry’s dynamics and steering companies towards transformative change. The focus of this analysis is to delve into the sustainability key performance indicators (KPIs) of prominent pharmaceutical players, namely Pfizer, Sanofi, Glaxo Smith Kline (GSK), Becton Dickinson, Johnson & Johnson, Abbott, Eli Lilly, and...